SAN DIEGO (Reuters Health) - Adding support to a controversial theory linking
aluminum with Alzheimer's disease, new research indicates the disease is more
common in regions of northwest Italy where levels of aluminum in drinking water
are highest.
And when the investigators studied the effects of one form of the metal on
two types of human cells in the lab, they found it hastened cell death.
"We were absolutely surprised by these results," said study author Dr. Paolo
Prolo, a researcher at the University of California at Los Angeles. "I did not
expect any effect from aluminum."
In findings released here Monday at the annual Experimental Biology meeting,
Prolo and colleagues focused on monomeric -- single molecule -- aluminum. This
is the type that can be most easily absorbed by human cells, he said.
While there have been suggestions that aluminum cookware might pose a risk
for Alzheimer's, the type of aluminum used in pots and pans consists of multiple
molecules and does not appear to affect human cells, according to Prolo. "There
is almost no evidence that the cookware is dangerous," he said.
When the researchers tested water in regions of northwest Italy in 1998, they
found that total aluminum levels -- including monomeric and other types of
aluminum -- ranged from 5 to 1,220 micrograms per liter, while monomeric
aluminum levels alone ranged from 5 to 300 micrograms per liter.
Environmental officials generally recommended that total aluminum levels be
below 200 micrograms per liter, Prolo noted.
After comparing this data to death rates from Alzheimer's in those regions,
the researchers found that the disease was more common in areas with the highest
levels of monomeric aluminum.
Back in the lab, Prolo and colleagues then tested the effects of monomeric
aluminum on human immune-system cells and bone cancer cells. Ideally, human
brain cells would be tested but these are not readily available because a biopsy
of a patient's brain is necessary to acquire them, he said.
"We found that a very low quantity of aluminum added to our cell cultures was
modifying cellular processes" like normal cell death, Prolo told Reuters Health.
When the aluminum was paired with beta-amyloid, a protein found in the brains
of Alzheimer's patients, the combination killed off even more cells.
Because aluminum could kill both types of human cells, these findings raise
the question of whether aluminum is potentially involved in other diseases,
Prolo said.
But much more research is needed to understand how the metal does or does not
affect people, he added.
Copyright 2002 Reuters. Reuters content is the
intellectual property of Reuters. Any copying, republication or redistribution
of Reuters content, including by caching, framing or similar means, is expressly
prohibited without the prior written consent of Reuters. Reuters shall not be
liable for any errors or delays in content, or for any actions taken in reliance
thereon. Reuters, the Reuters Dotted Logo and the Sphere Logo are registered
trademarks of the Reuters group of companies around the world.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
Sandy's Scandals Column
Past and current Scandals
- columns by Sandy Gottstein (aka Mintz)*
* ►February 8, 2010 - Inovio
Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related
Immune Response in Clinical Trial - Inovio via BusinessWire
via Technology Marketing Corporation - "VGX-3100 is a DNA vaccine
targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16
and 18 and is delivered via in vivo electroporation. Similar to
previously reported data from the initial lowest dose cohort of this
phase I trial, the vaccine was found to be generally safe and well
tolerated. While previously reported data showed significant cellular
and humoral immune responses, data from this second, intermediate dose
group highlighted a significantly increased and dose-related immune
response specific to the antigens targeted by the vaccine."..."While
recent HPV preventive vaccines have been successful in protecting
against infections that may lead to cervical cancer, Inovio's
therapeutic vaccine targets the millions of women already infected with
HPV and is intended to treat pre-cancerous cells and cervical cancer
caused by this virus. Current vaccines do not serve this group of
women," Dr. Kim added."
* ►February 6, 2010 - Autism
Findings Retracted
- The New American - "Actress Holly Robinson Peete remembers, 'When my
son was two-and-a-half, he was just recovering from an ear infection
and had been on antibiotics, therefore his immune system was
suppressed. He had already missed several appointments for his
vaccination so his pediatrician wanted to catch him up on all of them
in the same day. Althrough I asked if he’d consider waiting or breaking
up the cocktail, which contains three viruses, he laughed me out of the
office and belittled me. I firmly believe that it took my son to a
place of no return and his body could not handle it. He had a violent
reaction with convulsions and then he stopped talking and slipped into
a silence. He no longer said, 'Hi, Mommy,' he no longer responded to
his name and he no longer made eye contact.”